Surgeons, Hospitals Involved in Exceptional Research Have Lower Patient Mortality Rates, Fewer Complications

Lower Patient Mortality Rates

Surgeons and hospitals who conduct the most leading-edge research achieve lower rates of patient mortality and complications than those who do not, according to findings released today by Avant-garde Health.

Patients under the care of top surgeon-researchers showed a 5% lower rate of post-discharge complications and a 5% lower rate of mortality, within 30 days post-discharge, according to the research.

Derek Haas, CEO of Avant-garde Health

“The findings clearly show that being a better researcher is associated with being a better clinician. It is impressive that excellence in one domain does not come at the expense of the other.”

Evaluation of Medical Research

Avant-garde Health evaluated the quality and quantity of medical research published by 90,000 surgeons at 4,000 U.S. hospitals, across 10 specialties: general surgery, surgical oncology, orthopedic surgery, spine surgery, neurosurgery, cardiac and cardiothoracic surgery, vascular surgery, gastroenterology, urology and otolaryngology (ear, nose and throat). Avant-garde Health reviewed 2021-2022 Medicare Fee-for-Service data on 1.8 million cases from the Centers for Medicare and Medicaid Services. All research appeared on PubMed and was weighted using Journal Impact Factor and author position. Additional study methodology can be reviewed in detail here.

In connection with the groundbreaking research, Avant-garde Health also announced today the Healthcare Research All-Stars for 2024, representing the top 5% of surgeons and hospitals who have authored leading-edge research in one of the 10 specialties. All 4,500 physicians and 350 hospitals being honored are listed on the Research All-Stars site.

Top surgeon-researchers had a remarkable output, with an average publication rate of 11 articles per year. This contrasts sharply with the broader group of surgeons, whose average stands at just 0.5 articles annually. In addition, a significant portion of the top surgeon-researchers – 47.1% on average – served as the leading or senior authors of their research.

“This collective effort and leadership in research underscores the pivotal role of these surgeons in driving medical innovations and enhancing patient care practices,” said Dr. Porter Jones, M.D., vice president of clinical transformation for Avant-garde Health.

In addition, women are about 20% more likely to be in the top 5% of researchers in their clinical field when compared with their male counterparts, underscoring progress toward diversity and inclusion in healthcare research.

Research All-Star Dr. Lisa Cannada, M.D., an orthopedic trauma surgeon for Novant Health, spoke of this necessary progress, “Diversity in the field of orthopedics has been a cornerstone of my work, ensuring that we create an inclusive environment where the voices of women are heard and valued. Alongside this, my commitment to evidence-based medicine has [resulted in] over 200 [article] publications, highlighting the importance of rigorous research in advancing patient care.”

Avant-garde Health routinely conducts research that has appeared in Harvard Business Review, The New England Journal of Medicine and JAMA. Avant-garde annually produces an average of 10 high-quality research manuscripts for publications that advance understanding of the cost, quality and value of care, as well as disparities in treatment, and apply these insights to improve care quality and patient outcomes.

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.